A 35-year-old Myrtle Creek woman was arrested in connection to a weeks-long alleged cocaine trafficking investigation. The ...

Patients with a common heart rhythm disorder who took an experimental blood-thinning drug had far fewer bleeding episodes ...

People using weed for medical purposes are as likely -- or more -- to become addicted to cannabis as recreational tokers, a ...

As more cases of bird flu emerge across the country, public health leaders in New York City are watching warily -- and making ...

Based on a survey of cardiologist and pulmonologists treating patients for pulmonary arterial hypertension (PAH), analysts at ...

A new study suggests that a pill used for emergency contraception could be repurposed at a higher dose as an abortion drug, ...

Five magnificent income stocks -- sporting an average yield of 4.26% -- can pad investors' pocketbooks in the new year (and well beyond).

Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug ...

From humble beginnings to becoming the Vice President of the United States, Speaker Mike Johnson captured the special moment ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.